18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

Clinical trial NCT00791063 · COMPLETED

Trial details

NCT number: NCT00791063
Sponsor: Aposense Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Brain Metastases

Start date: 2008-03-01
Primary completion: 2008-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.